Antibiotic consumption in Turkish hospitals; a multi-centre point prevalence study

Basit Öğe Kaydı
dc.contributor.authorGuclu, Ertugrul
dc.contributor.authorOgutlu, Aziz
dc.contributor.authorKarabay, Oguz
dc.contributor.authorDemirdal, Tuna
dc.contributor.authorErayman, Ibrahim
dc.contributor.authorHosoglu, Salih
dc.contributor.authorTurhan, Vedat
dc.date.accessioned2024-04-24T16:25:00Z
dc.date.available2024-04-24T16:25:00Z
dc.date.issued2017
dc.departmentDicle Üniversitesien_US
dc.description.abstractThis multi-centre study aimed to determine the antibiotic consumption in Turkish hospitals by point prevalence. Antibiotic consumption of 14 centres was determined using the DDD method. Among hospitalized patients, 44.8% were using antibiotics and the total antibiotic consumption was 674.5 DDD/1000 patient-days (DPD). 189.6 (28%) DPD of the antibiotic consumption was restricted while 484.9 (72%) DPD was unrestricted. Carbapenems (24%) and beta lactam/beta lactamase inhibitors (ampicillin-sulbactam or amoxicillin-clavulanate; 22%) were the most commonly used restricted and unrestricted antibiotics. Antibiotics were most commonly used in intensive care units (1307.7 DPD). Almost half of the hospitalized patients in our hospitals were using at least one antibiotic. Moreover, among these antibiotics, the most commonly used ones were carbapenems, quinolones and cephalosporins, which are known to cause collateral damage. We think that antibiotic resistance, which is seen at considerably high rates in our hospitals, is associated with this level of consumption.en_US
dc.identifier.doi10.1080/1120009X.2016.1156893
dc.identifier.endpage24en_US
dc.identifier.issn1120-009X
dc.identifier.issn1973-9478
dc.identifier.issue1en_US
dc.identifier.pmid27238248
dc.identifier.scopus2-s2.0-84978471870
dc.identifier.scopusqualityQ3
dc.identifier.startpage19en_US
dc.identifier.urihttps://doi.org/10.1080/1120009X.2016.1156893
dc.identifier.urihttps://hdl.handle.net/11468/16923
dc.identifier.volume29en_US
dc.identifier.wosWOS:000396680900004
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofJournal of Chemotherapy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntibioticen_US
dc.subjectAntibiotic Stewardshipen_US
dc.subjectConsumptionen_US
dc.subjectHospitalen_US
dc.titleAntibiotic consumption in Turkish hospitals; a multi-centre point prevalence studyen_US
dc.titleAntibiotic consumption in Turkish hospitals; a multi-centre point prevalence study
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu